Singapore markets closed

Cyclerion Therapeutics, Inc. (CYCN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.4500+0.0400 (+1.66%)
As of 10:58AM EST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
297
3,320
2,296
4,507
Operating expenses
Research development
28,181
31,493
37,636
56,414
95,140
Selling general and administrative
11,286
14,504
20,620
28,816
34,404
Total operating expenses
38,139
44,669
57,634
85,230
129,544
Operating income or loss
-38,139
-44,372
-54,314
-82,934
-125,037
Interest expense
-
-
16
-
-
Total other income/expenses net
-
-
2,683
4,544
-
Income before tax
-41,054
-44,078
-51,647
-77,802
-123,008
Income from continuing operations
-41,054
-44,078
-51,647
-77,802
-123,008
Net income
-10,785
-44,078
-51,647
-77,802
-123,008
Net income available to common shareholders
-10,785
-44,078
-51,647
-77,802
-123,008
Basic EPS
-13.06
-20.20
-26.40
-51.20
-89.80
Diluted EPS
-13.06
-20.20
-26.40
-51.20
-89.80
Basic average shares
2,202
2,173
1,957
1,520
1,369
Diluted average shares
2,202
2,173
1,957
1,520
1,369